SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Oral Allergy Immunotherapy Helps Control Asthma, Medical University of Genoa, Italy Study
March 4, 2008
 · 
1 min read
Drug Development
Common Rheumatoid Arthritis Drug Won’t Raise Blood Cancer Risk
March 3, 2008
 · 
1 min read
Drug Development
New Study of Targeted Therapies for Breast Cancer Establishes Model for Global Clinical Trials
February 29, 2008
 · 
1 min read
Drug Development
Vasopressin Offers No Survival Benefit for Septic Shock, University of British Columbia Study
February 28, 2008
 · 
1 min read
Drug Development
Clinical Trial Boosts Epicor’s Efficacy For Immune Health
February 27, 2008
 · 
1 min read
Drug Development
FDA Plans New Post-Approval Drug Safety Effort
February 27, 2008
 · 
1 min read
Drug Development
Study Questions Antibiotics For Dementia Patients
February 26, 2008
 · 
1 min read
Drug Development
University of Hull Study Doubts Effectiveness Of Antidepressant Drugs
February 26, 2008
 · 
1 min read
Drug Development
Tests Of New AIDS Gel Show Promise For Women
February 25, 2008
 · 
1 min read
Drug Development
Antibiotic May Prevent Dreaded Brain Fever, Study Suggests
February 22, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Celgene Corporation Drug Revlimid Increases Risk of Certain New Cancers
May 8, 2012
 · 
1 min read
Drug Development
Alere Inc. Release: Preliminary Results of Prospective Trial Suggest Warfarin May be a Safer Option for Patients than Alternative Therapies
May 7, 2012
 · 
1 min read
Drug Development
Dainippon Sumitomo Pharma Co., Ltd. Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase III Trials in Bipolar I Depression
May 7, 2012
 · 
16 min read
Drug Development
Pfizer Inc.'s Pristiq Shows Positive Results in Long-Term Study
May 7, 2012
 · 
13 min read
Drug Development
Studies Reveal How Merck & Co., Inc.'s Vioxx Raises Heart Risks
May 3, 2012
 · 
1 min read
Drug Development
Genentech Says SUMMACTA Study Meets Primary Endpoint
May 3, 2012
 · 
5 min read
Drug Development
Roche’s Avastin and Novartis AG’s Lucentis Equal for Treating Wet AMD - National Institutes of Health (NIH) Study
May 1, 2012
 · 
7 min read
Drug Development
New Tysabri Data Presented at 64th Annual American Academy of Neurology Meeting Highlight Biogen Idec, Inc. (Massachusetts) & Biogen Idec, Inc. (Massachusetts) Commitment to Improving Outcomes in Multiple Sclerosis
April 27, 2012
 · 
1 min read
Drug Development
UCB, Inc. Release: Interim results of VITOBA(TM) (VImpaT(R) added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
April 27, 2012
 · 
12 min read
Drug Development
UCB Group Release: New Post-Hoc Analyses Examined Neupro® Effects on Pain, Depressed Mood, Apathy and Fatigue in Patients with Parkinson’s Disease
April 26, 2012
 · 
1 min read
Drug Development
Preliminary Data Suggest Spasticity May Be Reduced in Relapsing-Remitting Multiple Sclerosis Patients Who Transitioned to Teva Pharmaceutical Industries Limited’s COPAXONE®
April 26, 2012
 · 
1 min read
Drug Development
Shire plc Reports Positive Phase 2 Study Met Primary End Point for Investigative Use of Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) in Adults With Binge Eating Disorder
April 26, 2012
 · 
10 min read
Drug Development
UCB Group Release: First Assessment of Individual RLS Domains in New Post-Hoc Analyses of Neupro® Studies
April 25, 2012
 · 
1 min read
Drug Development
Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
April 25, 2012
 · 
6 min read
Drug Development
Mera Pharmaceuticals, Inc. Release: XEOMIN® (incobotulinumtoxinA) Data to be Presented at the 64th Annual Meeting of the American Academy of Neurology
April 23, 2012
 · 
8 min read
Drug Development
UCB, Inc. Release: New Neupro(R) Data in Parkinson’s Disease and Restless Legs Syndrome to be Presented at the 64th American Academy of Neurology
April 23, 2012
 · 
12 min read
Drug Development
Bayer AG’s Once-Daily Oral Anticoagulant Receives Positive Common Drug Review Recommendation for Stroke Prevention in Atrial Fibrillation
April 23, 2012
 · 
4 min read
Drug Development
NovaBay Pharmaceuticals, Inc.'s NeutroPhase(R) Supports Healing of Chronic Wounds
April 19, 2012
 · 
1 min read
Drug Development
Boehringer Ingelheim Pharmaceuticals, Inc. Release: Dabigatran Etexilate (Pradaxa®) Associated with Significantly Lower Rates of Fatal and Traumatic Intracranial Haemorrhage Compared with Warfarin
April 18, 2012
 · 
1 min read
Drug Development
Cubist Pharmaceuticals, Inc. Announces Positive Results from ENTEREG® Phase 4 Study in Patients Undergoing Radical Cystectomy
April 18, 2012
 · 
6 min read
Load More